Keith Kennedy

Keith Kennedy is a seasoned researcher in the field of biotransformation with extensive experience in pharmaceutical development. Currently serving as a Senior Research Investigator at Isomorphic Labs since September 2025, Keith previously held the position of Research Investigator at Incyte from August 2017 to September 2025, where responsibilities included leading biotransformation efforts for multiple discovery programs, collaborating across departments, and ensuring compliance with regulatory guidelines. Earlier roles included research positions at Frontier Scientific and the University of Pittsburgh, culminating in a Master's degree in Pharmaceutical Sciences from the University of Florida and a Bachelor's degree in Chemistry from the University of Pittsburgh.